Drug name - Qelbree

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9603853 SUPERNUS PHARMS Formulations of viloxazine Feb, 2033

(10 years from now)

US9358204 SUPERNUS PHARMS Formulations of viloxazine Feb, 2033

(10 years from now)

US9662338 SUPERNUS PHARMS Formulations of viloxazine Feb, 2033

(10 years from now)

Drugs and Companies using VILOXAZINE HYDROCHLORIDE ingredient

Treatment: For the treatment of attention deficit hyperactivity disorder (adhd)

Dosage: CAPSULE, EXTENDED RELEASE;ORAL

More Information on Dosage
Strength Dosage Availability
EQ 100MG BASE CAPSULE, EXTENDED RELEASE;ORAL Prescription
EQ 150MG BASE CAPSULE, EXTENDED RELEASE;ORAL Prescription
EQ 200MG BASE CAPSULE, EXTENDED RELEASE;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.